Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aptevo Therapeutics Inc.

    NASDAQ: APVO · Real-Time Price · USD
    3.69
    0.03 (0.82%)
    At close: Jun 17, 2025, 10:23 AM

    Aptevo Therapeutics Statistics

    Share Statistics

    Aptevo Therapeutics has 700K shares outstanding. The number of shares has increased by 0.01% in one year.

    Shares Outstanding

    n/a
    		 700K

    Shares Change (YoY)

    n/a
    		 0.01%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 15.37%

    Shares Floating

    n/a
    		 700K

    Failed to Deliver (FTD) Shares

    n/a
    		 4,105

    FTD / Avg. Volume

    n/a
    		 1.48%

    Short Selling Information

    The latest short interest is 9.4K, so 1.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 9.4K

    Short % of Shares Out

    n/a
    		 1.39%

    Short % of Float

    n/a
    		 1.39%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.99 and the forward PE ratio is -0.02. Aptevo Therapeutics's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 -0.99

    Forward PE

    n/a
    		 -0.02

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 5.01

    P/FCF Ratio

    n/a
    		 -1

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aptevo Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.97.

    Current Ratio

    n/a
    		 1.72

    Quick Ratio

    n/a
    		 1.72

    Debt / Equity

    n/a
    		 0.97

    Debt / EBITDA

    n/a
    		 -0.19

    Debt / FCF

    n/a
    		 -0.19

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-652,162.16

    Employee Count

    n/a
    		 37

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -99.19% in the last 52 weeks. The beta is 5.73, so Aptevo Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 5.73

    52-Week Price Change

    n/a
    		 -99.19%

    50-Day Moving Average

    n/a
    		 10.19

    200-Day Moving Average

    n/a
    		 98.64

    Relative Strength Index (RSI)

    n/a
    		 24.15

    Average Volume (20 Days)

    n/a
    		 277,384

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -24.6M

    Net Income

    n/a
    		 -24.13M

    EBITDA

    n/a
    		 -23.78M

    EBIT

    n/a
    		 -24.13M

    Earnings Per Share (EPS)

    n/a
    		 -84.67
    Full Income Statement

    Balance Sheet

    The company has 8.71M in cash and 4.63M in debt, giving a net cash position of 4.08M.

    Cash & Cash Equivalents

    n/a
    		 8.71M

    Total Debt

    n/a
    		 4.63M

    Net Cash

    n/a
    		 4.08M

    Retained Earnings

    n/a
    		 -247.58M

    Total Assets

    n/a
    		 8.34M

    Working Capital

    n/a
    		 -1.79M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -23.79M and capital expenditures 0, giving a free cash flow of -23.79M.

    Operating Cash Flow

    n/a
    		 -23.79M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -23.79M

    FCF Per Share

    n/a
    		 -86.13
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    APVO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for APVO is $5920, which is 161207.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5920

    Price Target Difference

    n/a
    		 161207.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 27, 2025. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 May 27, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -52.22

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist